pmc-enju-pas Home  

PMC:1064895 / 1252-1418 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T849 2-5 DT denotes The
T850 6-16 NN denotes production
T851 17-19 IN denotes of
T852 20-25 NN denotes IL-17
T853 26-29 VB denotes was
T854 30-43 RB denotes significantly
T855 44-53 VB denotes increased
T856 54-56 IN denotes in
T857 57-62 NN denotes cells
T858 63-70 VB denotes treated
T859 71-75 IN denotes with
T860 76-84 JJ denotes anti-CD3
T861 85-93 NN denotes antibody
T862 94-98 IN denotes with
T863 99-101 CC denotes or
T864 102-109 IN denotes without
T865 110-119 NN denotes anti-CD28
T866 120-123 CC denotes and
T867 124-127 NN denotes PHA
T868 128-129 -LRB- denotes (
T869 129-130 NN denotes P
T870 131-132 SYM denotes <
T871 133-137 CD denotes 0.05
T872 137-138 -RRB- denotes )
T873 140-145 IN denotes Among
T874 146-152 VB denotes tested
T875 153-162 NN denotes cytokines
T876 163-166 CC denotes and
R298 T850 T849 arg1Of production,The
R299 T850 T851 arg1Of production,of
R300 T850 T853 arg1Of production,was
R301 T850 T855 arg2Of production,increased
R302 T852 T851 arg2Of IL-17,of
R303 T855 T853 arg2Of increased,was
R304 T855 T854 arg1Of increased,significantly
R305 T855 T856 arg1Of increased,in
R306 T857 T856 arg2Of cells,in
R307 T857 T858 arg2Of cells,treated
R308 T858 T859 arg1Of treated,with
R309 T861 T859 arg2Of antibody,with
R310 T861 T860 arg1Of antibody,anti-CD3
R311 T861 T862 arg1Of antibody,with
R312 T861 T864 arg1Of antibody,without
R313 T862 T863 arg1Of with,or
R314 T864 T863 arg2Of without,or
R315 T865 T866 arg1Of anti-CD28,and
R316 T866 T862 arg2Of and,with
R317 T866 T864 arg2Of and,without
R318 T866 T868 arg1Of and,(
R319 T867 T866 arg2Of PHA,and
R320 T869 T868 arg2Of P,(
R321 T869 T870 arg1Of P,<
R322 T869 T871 arg1Of P,0.05
R323 T872 T868 arg3Of ),(
R324 T875 T876 arg1Of cytokines,and
R325 T876 T873 arg2Of and,Among
R326 T876 T874 arg2Of and,tested